右美托咪定滴鼻在麻醉中的研究进展  

Research Progress of Dexmedetomidine Nasal Drops in Anesthesia

作　　者：高萌[1] 罗志锴[1] 张二飞[1] 

机构地区：[1]延安大学附属医院,陕西 延安

出　　处：《医学诊断》2020年第3期132-136,共5页Medical Diagnosis

摘　　要：右美托咪定(dexmedetomidine, DEX)作为一种新α2肾上素受体激动剂,因其良好的镇静、镇痛、抗焦虑、稳定血流动力学、抑制腺体分泌,并无呼吸抑制作用,现广泛应用于围术期术前镇静。右美托咪定滴鼻是一种新型的给药方式,具有起效快、生物利用度高、操作简单等优势,现已逐渐被应用于临床。Dexmedetomidine, as a new α2 receptor agonist, is widely used for perioperative sedation due to its excellent sedation, analgesia, anti-anxiety, stable hemodynamics, inhibitory effect on gland se-cretion, and no respiratory inhibition. Dexmedetomidine nasal drop is a new drug delivery method, which has the advantages of fast onset, high bioavailability and simple operation, and has been gradually applied in clinical practice.

关 键 词：右美托咪定滴鼻 

分 类 号：R61[医药卫生—外科学]